The retraction of three papers on treating COVID-19 with hydroxychloroquine reflect a crisis in the scientific community: how to handle data from private companies. What reforms are necessary to avoid such data-based scandals in the future?
Those in rural areas face a significantly higher risk of death from common causes than their urban counterparts. Is telemedicine the solution to this disparity?
Is healthcare like any other consumer good in the marketplace or does it occupy a privileged position that requires special protections? Our answer has far-reaching implications.
Egg donation holds invaluable promise for many, but it is also rife with societal implications for all.
The recent passing of Belgian Paralympian Marieke Vervoort prompts reflection on the thorny issues surrounding aid in dying legislation.
NDs and MDs are both concerned for the public's health and patient autonomy, but is formally distinguishing NDs from unlicensed practitioners an advancement of, or a hindrance to, those goals?
A recent case highlights the conflict between paternalism and autonomy in the medical field. In what sense might one's decision to pursue an experimental treatment not be one's own?
Developing human/non-human embryos for research and organ transplant raises tough questions about the value of human life and the politics of species taxonomy.
In the debate over vaccination abstention, the right to refuse medical treatment and the right to bodily integrity are in conflict with concerns of justice and public health. How can we make headway in the deadlock?
Emerging healthcare technologies like Rudy, Addison, and PARO should prompt us to reassess the healthcare industry and to contemplate the difference between service and care.